DR. STEVEN ALLAN MADDEN MD NPI 1538198171

NPI Details

DR. Steven Allan Madden, MD is a hematology and oncology internal medicine in West Columbia, SC with 50 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Steven Allan Madden, MD NPI is 1538198171. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Graduation Year:1976

The provider's business location address is:

222 E MEDICAL LN STE 400
WEST COLUMBIA, SC
ZIP 29169-848
Phone: (803) 794-7511
Fax: (803) 794-7751

The NPI 1538198171 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev (HCPCS:G6013)
• Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Magnesium level (HCPCS:83735)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Ct guidance for insertion of radiation therapy fields (HCPCS:77014)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Ct scan of chest with contrast (HCPCS:71260)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Adrenocorticotropic hormone (acth) level (HCPCS:82024)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Automated urinalysis test (HCPCS:81003)
• Blood creatinine level (HCPCS:82565)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Drawing of blood for a medical problem (HCPCS:99195)
• Blood test, clotting time (HCPCS:85610)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Ct scan of chest without contrast (HCPCS:71250)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection of drug or substance into vein (HCPCS:96374)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 7/3/2006 and was last updated on 3/15/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.